Operating Lease, Right-of-Use Asset of Eton Pharmaceuticals, Inc. from 02 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eton Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 02 Jan 2019 to 30 Sep 2025.
  • Eton Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $319,000, a 65% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Eton Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $319,000 +$126,000 +65% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $324,000 +$105,000 +48% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $158,000 +$84,000 +114% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $175,000 +$83,000 +90% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $193,000 +$84,000 +77% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $219,000 +$70,000 +47% 30 Jun 2024 10-K 18 Mar 2025 2024 FY
Q1 2024 $74,000 -$95,000 -56% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $92,000 -$96,000 -51% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $109,000 +$67,000 +160% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $149,000 +$86,000 +137% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $169,000 +$85,000 +101% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $188,000 +$84,000 +81% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $42,000 -$81,000 -66% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $63,000 -$80,000 -56% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $84,000 $0 0% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $104,000 -$88,000 -46% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $123,000 +$60,000 +95% 30 Sep 2021 10-Q 16 Nov 2021 2021 Q3
Q2 2021 $143,000 +$47,000 +49% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $84,000 -$45,000 -35% 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $192,000 +$32,000 +20% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 $63,000 -$128,000 -67% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $96,000 -$126,000 -57% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $129,000 -$123,000 -49% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $160,000 -$121,000 -43% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $191,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $222,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $252,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $281,000 02 Jan 2019 10-K 05 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.